Table of Contents Author Guidelines Submit a Manuscript
Journal of Oncology
Volume 2011, Article ID 741868, 5 pages
http://dx.doi.org/10.1155/2011/741868
Research Article

Pancreatic Cancer Cell Lines Can Induce Prostaglandin E2 Production from Human Blood Mononuclear Cells

Infection and Cancer Program, Abteilung F010 and Inserm U701, Deutsches Krebsforschungszentrum, 69120 Heidelberg, Germany

Received 18 February 2011; Revised 19 May 2011; Accepted 6 June 2011

Academic Editor: Thomas E. Adrian

Copyright © 2011 Svitlana P. Grekova et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Jemal, R. Siegel, E. Ward, T. Murray, J. Xu, and M. J. Thun, “Cancer statistics, 2007,” CA Cancer Journal for Clinicians, vol. 57, no. 1, pp. 43–66, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Juuti, J. Louhimo, S. Nordling, A. Ristimäki, and C. Haglund, “Cyclooxygenase-2 expression correlates with poor prognosis in pancreatic cancer,” Journal of Clinical Pathology, vol. 59, no. 4, pp. 382–386, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  3. P. Mukherjee, G. D. Basu, T. L. Tinder et al., “Progression of pancreatic adenocarcinoma is significantly impeded with a combination of vaccine and COX-2 inhibition,” Journal of Immunology, vol. 182, no. 1, pp. 216–224, 2009. View at Google Scholar · View at Scopus
  4. K. F. Scott, M. Sajinovic, J. Hein et al., “Emerging roles for phospholipase A2 enzymes in cancer,” Biochimie, vol. 92, no. 6, pp. 601–610, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. R. P. Phipps, S. H. Stein, and R. L. Roper, “A new view of prostaglandin E regulation of the immune response,” Immunology Today, vol. 12, no. 10, pp. 349–352, 1991. View at Google Scholar · View at Scopus
  6. J. P. Edwards and L. A. Emens, “The multikinase inhibitor Sorafenib reverses the suppression of IL-12 and enhancement of IL-10 by PGE2 in murine macrophages,” International Immunopharmacology, vol. 10, no. 10, pp. 1220–1228, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  7. F. G. Snijdewint, P. Kalinski, E. A. Wierenga, J. D. Bos, and M. L. Kapsenberg, “Prostaglandin E2 differentially modulates cytokine secretion profiles of human T helper lymphocytes,” Journal of Immunology, vol. 150, no. 12, pp. 5321–5329, 1993. View at Google Scholar · View at Scopus
  8. C. M. Hilkens, A. Snijders, H. Vermeulen, P. H. Van Der Meide, E. A. Wierenga, and M. L. Kapsenberg, “Accessory cell-derived IL-12 and prostaglandin E2 determine the IFN-γ level of activated human CD4+ T cells,” Journal of Immunology, vol. 156, no. 5, pp. 1722–1727, 1996. View at Google Scholar · View at Scopus
  9. J. Chu, F. L. Lloyd, O. C. Trifan, B. Knapp, and M. T. Rizzo, “Potential involvement of the cyclooxygenase-2 pathway in the regulation of tumor-associated angiogenesis and growth in pancreatic cancer,” Molecular Cancer Therapeutics, vol. 2, no. 1, pp. 1–7, 2003. View at Google Scholar · View at Scopus
  10. J. K. Colby, R. D. Klein, M. J. McArthur et al., “Progressive metaplastic and dysplastic changes in mouse pancreas induced by cyclooxygenase-2 overexpression,” Neoplasia, vol. 10, no. 8, pp. 782–796, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. N. Omura, M. Griffith, A. Vincent et al., “Cyclooxygenase-deficient pancreatic cancer cells use exogenous sources of prostaglandins,” Molecular Cancer Research, vol. 8, no. 6, pp. 821–832, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  12. S. Hasan, M. Satake, D. W. Dawson et al., “Expression analysis of the prostaglandin E2 production pathway in human pancreatic cancers,” Pancreas, vol. 37, no. 2, pp. 121–127, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  13. C. M. Schmidt, M. T. Yip-Schneider, M. C. Ralstin et al., “PGE(2) in pancreatic cyst fluid helps differentiate IPMN from MCN and predict IPMN dysplasia,” Journal of Gastrointestinal Surgery, vol. 12, no. 2, pp. 243–249, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  14. S. Yoshida, M. Ujiki, X. Z. Ding et al., “Pancreatic stellate cells (PSCs) express cyclooxygenase-2 (COX-2) and pancreatic cancer stimulates COX-2 in PSCs,” Molecular Cancer, vol. 4, p. 27, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  15. C. E. Clark, S. R. Hingorani, R. Mick, C. Combs, D. A. Tuveson, and R. H. Vonderheide, “Dynamics of the immune reaction to pancreatic cancer from inception to invasion,” Cancer Research, vol. 67, no. 19, pp. 9518–9527, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  16. V. Tjomsland, P. Sandström, A. Spångeus et al., “Pancreatic adenocarcinoma exerts systemic effects on the peripheral blood myeloid and plasmacytoid dendritic cells: an indicator of disease severity?” BMC Cancer, vol. 10, p. 87, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  17. V. Tjomsland, A. Spångeus, P. Sandström, K. Borch, D. Messmer, and M. Larsson, “Semi mature blood dendritic cells exist in patients with ductal pancreatic adenocarcinoma owing to inflammatory factors released from the tumor,” PLoS One, vol. 5, no. 10, article e13441, 2010. View at Publisher · View at Google Scholar · View at PubMed
  18. C. C. Leslie, T. A. Gangelhoff, and M. H. Gelb, “Localization and function of cytosolic phospholipase A2alpha at the Golgi,” Biochimie, vol. 92, no. 6, pp. 620–626, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  19. F. Ghomashchi, A. Stewart, Y. Hefner et al., “A pyrrolidine-based specific inhibitor of cytosolic phospholipase A(2)alpha blocks arachidonic acid release in a variety of mammalian cells,” Biochimica et Biophysica Acta, vol. 1513, no. 2, pp. 160–166, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Gorovetz, O. Schwob, M. Krimsky, S. Yedgar, and R. Reich, “MMP production in human fibrosarcoma cells and their invasiveness are regulated by group IB secretory phospholipase A2 receptor-mediated activation of cytosolic phospholipase A2,” Frontiers in Bioscience, vol. 13, no. 5, pp. 1917–1925, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. A. N. Fonteh, G. I. Atsumi, T. LaPorte, and F. H. Chilton, “Secretory phospholipase A2 receptor-mediated activation of cytosolic phospholipase A2 in murine bone marrow-derived mast cells,” Journal of Immunology, vol. 165, no. 5, pp. 2773–2782, 2000. View at Google Scholar · View at Scopus
  22. M. Fogel-Petrovic, J. A. Long, D. A. Knight, P. J. Thompson, and J. W. Upham, “Activated human dendritic cells express inducible cyclo-oxygenase and synthesize prostaglandin E2 but not prostaglandin D2,” Immunology and Cell Biology, vol. 82, no. 1, pp. 47–54, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  23. H. Harizi and N. Gualde, “Dendritic cells produce eicosanoids, which modulate generation and functions of antigen-presenting cells,” Prostaglandins Leukotrienes and Essential Fatty Acids, vol. 66, no. 5-6, pp. 459–466, 2002. View at Publisher · View at Google Scholar · View at Scopus